For laboratory research use only — not for human or veterinary consumption.
The Peptide Index
Dosing guide

Noopept Dosage Chart & Schedule

Noopept is a synthetic dipeptide-derived nootropic (N-phenylacetyl-L-prolylglycine ethyl ester) developed in Russia and taken orally, not by injection. It is a prescription nootropic in Russia and sold elsewhere as a supplement, but it is not FDA-approved and robust independent clinical evidence is limited.

Route
Oral
Frequency
2-3x daily (oral)
Half-life
Very short plasma half
Storage
Store tablets or powder cool, dry, and out of light.
The short answer

Noopept is a synthetic dipeptide-derived nootropic taken orally, not by injection. Studies and label use report roughly 10 mg two to three times daily (about 20-30 mg/day); it is a prescription nootropic in Russia and a supplement in some markets, but it is not FDA-approved, so this is reported context.

Figures describe how Noopept is reported in the research literature and research-community references — not a recommendation for human use. For laboratory research only.

Dosage protocols

Commonly referenced research tiers. Start conservative; every compound and study context differs.

Starter
10 mg/day
Oral; 10 mg once daily
Frequency
Once daily
Weekly total
About 70 mg/week
Cycle
Studied in courses of weeks (e.g. about 1.5-2 months)

Single daily dose; low end of reported use.

Most commonStandard
20 mg/day
Oral; 10 mg twice daily
Frequency
10 mg twice daily
Weekly total
About 140 mg/week
Cycle
Studied in courses of weeks (e.g. about 1.5-2 months)

Within the commonly reported 20-30 mg/day range.

Maintenance
30 mg/day
Oral; 10 mg three times daily
Frequency
10 mg three times daily
Weekly total
About 210 mg/week
Cycle
Studied in courses of weeks (e.g. about 1.5-2 months)

Upper end of the reported daily range; reported context, not a recommendation.

Oral, not injected

  • Noopept is taken orally (tablet, capsule, or sublingual), not reconstituted or injected.
  • The parent compound has a half-life of minutes; activity is attributed largely to active metabolites.
  • Studies report about 10 mg two to three times daily (20-30 mg/day).

Regulatory status

  • A prescription nootropic in Russia and a supplement in some other markets.
  • Not FDA-approved; robust independent clinical evidence is limited.

Ready to run this protocol?

Dosing is only as good as the vial. Research-grade peptides are third-party tested with published COAs from our top-rated source — reconstitute with confidence and skip the guesswork on identity and purity.

Weekly schedule

A typical week on the standard protocol (10 mg twice daily).

Mon
Tue
Wed
Thu
Fri
Sat
Sun

Dosing day Off

Handling & storage

  • Oral compound taken as a tablet, capsule, or sublingual powder; no reconstitution.
  • The parent half-life is only minutes, so it is dosed 2-3 times per day in studies.
  • Store cool, dry, and out of direct light.
  • A supplement in some markets and a prescription nootropic in Russia; not FDA-approved.

Noopept dosing FAQ

What oral dose do noopept studies report?

Studies and label use report roughly 10 mg two to three times daily (about 20-30 mg/day). It is oral, not injected, and this is reported context, not a recommendation.

Why is it dosed 2-3 times a day?

The parent compound has a half-life of only minutes, so it is split through the day; activity is attributed largely to active metabolites.

Is noopept injected or reconstituted?

No. It is taken orally as a tablet, capsule, or sublingual powder; bacteriostatic water reconstitution does not apply.

Is noopept approved?

It is a prescription nootropic in Russia and a supplement in some other markets, but it is not FDA-approved.

Sources

Categories: Nootropic & Cognitive · Status: Approved (see notes). This page is educational and for laboratory research use only; it is not medical advice.